Published in Biotech Business Week, September 8th, 2003
Revenues increased 1.5% to $105.3 million for the second quarter ended June 30, 2003 from revenues of $103.8 million for the same quarter in 2002, an increase of $1.5 million. For the first 6 months of 2003, revenues increased 2.7% to $208.1 million from $202.6 million in the same period of the preceding year, a $5.5 million increase.
Alliance's earnings before interest, taxes, depreciation, and amortization, adjusted for non-cash stock-based compensation expenses, employment...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Biotech Business Week
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.